Hydrochlorothiazide and the Risk of Malignant Melanoma
JAMA Intern Med
.
2018 Oct 1;178(10):1425.
doi: 10.1001/jamainternmed.2018.4312.
Authors
Bert-Jan H van den Born
1
2
,
Rik Olde-Engberink
1
3
,
Liffert Vogt
1
3
Affiliations
1
Department of Internal Medicine, Academic Medical Centre, University of Amsterdam, Amsterdam, the Netherlands.
2
Department of Vascular Medicine, Academic Medical Centre, University of Amsterdam, Amsterdam, the Netherlands.
3
Department of Nephrology, Academic Medical Centre, University of Amsterdam, Amsterdam, the Netherlands.
PMID:
30285130
DOI:
10.1001/jamainternmed.2018.4312
No abstract available
Publication types
Comment
MeSH terms
Humans
Hydrochlorothiazide
Melanoma*
Skin Neoplasms*
Substances
Hydrochlorothiazide